Methylmalonate Overload Despite Glycemic Control Drives Diabetic Heart Damage
Circulation Research · 28.08.2026 · 139 (6)
DOI: 10.1161/circresaha.125.327192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 28.08.2026. Verfasst von Shanjie Wang und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, China (S.W., M.Y., Y.W., J.G., Z.C., X. Liu, Z.L., R.L., G.M., P.W…. Hauptthemen laut MEDLINE: Methylmalonic Acid, Glycemic Control, Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Despite optimal glycemic control, the heart failure burden remains substantial in diabetic patients. Metabolic remodeling is involved in this process, yet our current understanding is still in its infancy. Methylmalonic acid (MMA) is conventionally viewed as a marker of cobalamin (Cbl) deficiency. Paradoxically, MMA elevation-related cardiovascular mortality is more pronounced in diabetic patients with normal or high Cbl levels. This study investigated the mechanisms and translational significance of this contradictory MMA accumulation in the diabetic heart. METHODS: We analyzed serum Cbl, MMA, and cardiac biomarkers in 12 751 participants and characterized Mmut (methylmalonyl-CoA mutase; a key enzyme in MMA catabolism) expression in failing human hearts with diabetes. Cardiomyocyte-specific Mmut knockout and Mmut-overexpressing mice were subjected to high-fat diet/streptozotocin-induced diabetes. Molecular mechanisms were elucidated using 13 C-isotope tracing, RNA sequencing, immunoprecipitation, and biolayer interferometry. RESULTS: Elevated serum MMA was significantly associated with subclinical heart damage and adverse outcomes in diabetic adults, even in the absence of Cbl deficiency. Cardiac MMA overload and decreased protein expression of Mmut were observed in humans and mice with diabetes. Notably, MMA dysmetabolism preceded detectable cardiac dysfunction in diabetic mice and persisted even after glycemic normalization. Mechanistically, the hyperglycemic memory-associated molecule miR-499 binds to Mmut mRNA, suppressing its expression and driving MMA accumulation. Mmut deficiency amplified cardiac MMA overload and exacerbated disturbances in glycolipid metabolism and mitochondrial quality control, whereas adeno-associated virus-mediated Mmut overexpression attenuated cardiac MMA load and adverse remodeling in diabetic mice. Isotope tracing identified isoleucine and valine as the primary sources of cardiac MMA under diabetic conditions. Branched-chain amino acid-restricted diets alleviated diabetes-induced MMA accumulation and heart damage. Crucially, Cbl supplementation failed to alleviate MMA overload in diabetic mice, even at high doses or with activated forms. Strikingly, metformin, an established risk factor for Cbl deficiency, mitigated MMA-induced heart damage through dual mechanisms: activating AMPK (AMP-activated protein kinase)-dependent mitochondrial quality control to enhance tolerance to MMA, and directly promoting Mmut-Cbl cooperation to enhance MMA clearance. CONCLUSIONS: This study provides a foundation for understanding diabetes-related MMA dysmetabolism as a trigger for subclinical heart damage resistant to glycemic control and Cbl supplementation. Our findings challenge the prevailing clinical consensus regarding the impacts of Cbl and metformin use on MMA elevation in diabetic management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, China (S.W., M.Y., Y.W., J.G., Z.C., X. Liu, Z.L., R.L., G.M., P.W., Y.H., Y.L., Zeng Wang, X. Luo, H.C., Zhuozhong Wang, S.Y., S.F., B.…
- The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education and State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), China (S.W., M.Y., Y.W., J.G., Z.C., X. Liu, Z.L., R.L., G.M., P.W., Y.…
- Department of Epidemiology and Biostatistics, School of Public Health, Jiamusi University, China (Y.Z., F.T.).
- Department of Cardiology, First Affiliated Hospital of Jiamusi University, China (Y.C.).
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada (Y.S.).
- Department of Cardiology, Xijing Hospital of Fourth Military Medical University, Xi'an, China (W.G., D.S.).
ORCID-Profile: Shanjie Wang
Zitieren
APA
Wang, S., Yan, M., Zhang, Y., Tang, F., Wang, Y., Guo, J., Chen, Z., Liu, X., Li, Z., Lu, R., Cui, Y., Ma, G., Wu, P., Huang, Y., Liu, Y., Wang, Z., Luo, X., Cai, H., Shen, Y., …, & Yu, B. (2026). Methylmalonate Overload Despite Glycemic Control Drives Diabetic Heart Damage. Circulation Research, 139(6). https://doi.org/10.1161/circresaha.125.327192
Vancouver
Wang S, Yan M, Zhang Y, Tang F, Wang Y, Guo J, et al. Methylmalonate Overload Despite Glycemic Control Drives Diabetic Heart Damage. Circulation Research. 2026;139(6). doi:10.1161/circresaha.125.327192
BibTeX
@article{Wang2026,
author = {Wang, Shanjie and Yan, Miao and Zhang, Yiying and Tang, Fan and Wang, Ye and Guo, Junchen and Chen, Zhanchao and Liu, Xiaoxuan and Li, Zhaoying and Lu, Rongze and Cui, Yan and Ma, Guanpeng and Wu, Pengyan and Huang, Yuanyuan and Liu, Yige and Wang, Zeng and Luo, Xing and Cai, Hengxuan and Shen, Yanjiao and Ge, Wen and Wang, Zhuozhong and Yang, Shuang and Sun, Dongdong and Fang, Shaohong and Yu, Bo},
title = {Methylmalonate Overload Despite Glycemic Control Drives Diabetic Heart Damage},
journal = {Circulation Research},
year = {2026},
volume = {139},
number = {6},
doi = {10.1161/circresaha.125.327192}
}
EUVIMED